Instrument Inactif

Communiqués VIVUS, Inc. Nasdaq

Actions

US9285511005

Produits pharmaceutiques

Communiqués

14/12/20	VIVUS : Receives Court Approval of Joint Chapter 11 Plan of Reorganization	AQ
16/11/20	VIVUS : Seeks Bankruptcy Court Approval of Second Amended Joint Chapter 11 Plan of Reorganization and Existing Stock Record Date	AQ
16/11/20	VIVUS INC : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
13/07/20	VIVUS INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure (form 8-K)	AQ
07/07/20	VIVUS INC : Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
07/07/20	VIVUS Completes Solicitation for In-Court Reorganization Plan to Become a Wholly Owned Subsidiary of IEH Biopharma LLC	GL
19/06/20	VIVUS INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
02/06/20	VIVUS INC : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
02/06/20	VIVUS Announces Updated Agreement with Icahn Enterprises Holdings L.P.	GL
07/05/20	Vivus: 1Q Earnings Snapshot	AQ
06/05/20	VIVUS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
06/05/20	VIVUS Reports First Quarter 2020 Financial Results	GL
04/05/20	VIVUS : to Host First Quarter Business Update and Financial Results Conference Call on Wednesday, May 6, 2020	AQ
04/05/20	VIVUS : Announces Agreement with IEH Biopharma LLC Granting the Company a 30-Day Grace Period to Restructure its Corporate Debt	AQ
01/05/20	VIVUS to Host First Quarter Business Update and Financial Results Conference Call on Wednesday, May 6, 2020	GL
01/05/20	VIVUS Announces Agreement with IEH Biopharma LLC Granting the Company a 30-Day Grace Period to Restructure its Corporate Debt	GL
01/05/20	VIVUS INC : Entry into a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
03/04/20	VIVUS INC : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
03/04/20	VIVUS Announces Closing of $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules	GL
03/04/20	VitalTech : Partners with VIVUS Pharmaceuticals to Accelerate Launch of Telehealth and Remote Patient Monitoring Modules	PR
02/04/20	VIVUS INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
01/04/20	VIVUS : Announces $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules	AQ
01/04/20	VIVUS : Accelerates the Launch of Telemedicine and Remote Monitoring Modules to Facilitate Effective Patient Care during 'Social Distancing'	AQ
31/03/20	VIVUS INC : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
31/03/20	VIVUS Accelerates the Launch of Telemedicine and Remote Monitoring Modules to Facilitate Effective Patient Care During “Social Distancing”	GL